Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr;51(4):e16287.
doi: 10.1111/jog.16287.

Histological classification of uterine cervical adenocarcinomas: Its alteration and current status

Masanori Yasuda  1 , Tomomi Katoh  1 , Yu Miyama  1 , Taku Honma  1 , Mitsutake Yano  1 , Akira Yabuno  2
Affiliations
Review

Histological classification of uterine cervical adenocarcinomas: Its alteration and current status

Masanori Yasuda et al. J Obstet Gynaecol Res. 2025 Apr.

Abstract

Adenocarcinomas (ADCs) of the uterine cervix are relatively minor compared to squamous cell carcinomas. However, ADCs are histologically and histogenetically unique, especially because they can be with or without human papillomavirus (HPV) infection. At present, ADCs are divided into tumors as HPV-associated ADCs (HA-ADCs) and HPV-independent ADCs (HI-ADCs), including adenocarcinomas in situ (AIS) as their precursor, both of which consist of variable histological types. The usual-type accounts for the majority of HA-ADCs, and the gastric-type is a representative of HI-ADCs. Notably, it is clinicopathologically significant to differentiate between HA-ADCs and HI-ADCs because of the discrepancy in prognosis between them. Although relatively rare in comparison with HPV-associated AIS (HA-AIS), HPV-independent AIS (HI-AIS) has gradually attracted attention since gastric-type ADC (g-ADC) was introduced in the World Health Organization Classification 4th ed. (2014). Occasional HA-ADCs and HI-ADCs, including HA-AIS and HI-AIS, require p16 immunostaining, in situ hybridization, or HPV testing to differentiate between them because morphological features alone cannot often be conclusive for the diagnosis. A system focusing on the infiltrative pattern has been introduced due to its clinicopathological value. Staging criteria of HA-ADCs with polypoid/exophytic growth, recommended by the International Collaboration on Cancer Reporting, may supplement the International Federation of Gynecology and Obstetrics staging system for clinical management and treatment.

Keywords: adenocarcinoma in situ; human papillomavirus infection; uterus, cervix, adenocarcinoma.

PubMed Disclaimer

References

REFERENCES

    1. Park KJ, Selinger CI, Alvarado‐Cabrero I, Duggan MA, Kiyokawa T, Mills AM, et al. Dataset for the reporting of carcinoma of the cervix: recommendations from the international collaboration on cancer reporting (ICCR). Int J Gynecol Pathol. 2022;41(Suppl 1):S64–S89. https://doi.org/10.1097/PGP.0000000000000909
    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
    1. Talia KL, Oliva E, Rabban JT, Singh N, Stolnicu S, McCluggage WG. Grading of endocervical adenocarcinomas: review of the literature and recommendations from the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2021;40(Suppl 1):S66–S74.
    1. Kajiyama H, Tamauchi S, Takahashi F, Kawana K, Board members of the 2023 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology. Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: annual patient report for 2021 and annual treatment report for 2016. J Obstet Gynaecol Res. 2025;51(1):e16168.
    1. Nagase S, Ohta T, Takahashi F, Yaegashi N, Board members of the 2020 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology. Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: annual patient report for 2017 and annual treatment report for 2012. J Obstet Gynaecol Res. 2021;47(5):1631–1642. https://doi.org/10.1111/jog.14724

MeSH terms